Modulation of human type II secretory phospholipase A2 by sphingomyelin and annexin VI.
about
Interplay between lipoproteins and bee venom phospholipase A2 in relation to their anti-Plasmodium toxicity.Modulation of the activity of cytosolic phospholipase A2alpha (cPLA2alpha) by cellular sphingolipids and inhibition of cPLA2alpha by sphingomyelinInhibition of endothelial lipase activity by sphingomyelin in the lipoproteins.Dietary sphingomyelin lowers hepatic lipid levels and inhibits intestinal cholesterol absorption in high-fat-fed miceRegulation of phosphatidic Acid metabolism by sphingolipids in the central nervous systemRelationship between membrane physical properties and secretory phospholipase A2 hydrolysis kinetics in S49 cells during ionophore-induced apoptosis.Fecal metabolome of the Hadza hunter-gatherers: a host-microbiome integrative viewThe capacity of group V sPLA2 to increase atherogenicity of ApoE-/- and LDLR-/- mouse LDL in vitro predicts its atherogenic role in vivo.Sphingolipids and the orchestration of endothelium-derived vasoactive factors: when endothelial function demands greasing.Interleukin 1beta induces type II-secreted phospholipase A(2) gene in vascular smooth muscle cells by a nuclear factor kappaB and peroxisome proliferator-activated receptor-mediated process.Functional association of type IIA secretory phospholipase A(2) with the glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan in the cyclooxygenase-2-mediated delayed prostanoid-biosynthetic pathway.Mechanisms by which elevated intracellular calcium induces S49 cell membranes to become susceptible to the action of secretory phospholipase A2.Cholesterol relieves the inhibitory effect of sphingomyelin on type II secretory phospholipase A2.Ceramides increase the activity of the secretory phospholipase A2 and alter its fatty acid specificity.Effect of double bond geometry in sphingosine base on the antioxidant function of sphingomyelin.N-terminal and C-terminal plasma membrane anchoring modulate differently agonist-induced activation of cytosolic phospholipase A2.Effects of LDL lipids on activity of group IIA secretory phospholipase A2.On the binding preference of human groups IIA and X phospholipases A2 for membranes with anionic phospholipids.Phase composition of lipoprotein SM/cholesterol/PtdCho affects FA specificity of sPLA2s.Sphingomyelin Regulates the Activity of Secretory Phospholipase A2 in the Plasma Membrane.Modulation of the activity and arachidonic acid selectivity of group X secretory phospholipase A2 by sphingolipids.Novel physiological function of sphingomyelin in plasma. Inhibition of lipid peroxidation in low density lipoproteins.
P2860
Q33239549-0379999B-53FD-4133-AFF4-16C1D49A8CC8Q33741175-703708CB-5220-48E3-A282-AD15B13AA96CQ34243457-4F41847E-F53F-454A-A846-13930992079DQ34586490-5EEEEAE4-4A19-49F4-B838-1DB3415995C1Q34745605-ECFBC15F-4B38-450C-85E9-6893308AA3A1Q35972976-FA213F8F-63A2-4DC5-9A46-D49F049120DAQ37254281-DC1F033D-7658-4FEE-8CD1-C58F68C2516DQ37435082-FF9FEA33-388E-4ADC-A4DF-E4C82F61504EQ37686257-55A34D69-8B19-4B99-A881-3C76785C9BDBQ38321993-842F0F20-6E36-41E4-8B1C-C546C636506BQ40924363-6BE5204B-A19E-4A9B-90A2-B3923471BDC1Q40960247-A98A3D74-8510-4743-B308-35E2E0803793Q41813309-2F61FE2E-5835-4CB2-979D-A0D02F7A766DQ41891581-7E583929-9972-40BA-B83B-25BB3C30D240Q42089020-A6CE502A-5BD7-40F2-A36B-FC7F6C0CBCE0Q42478631-47C97E76-5CDB-45AB-9574-91680D63089FQ42778006-B3C0B617-91C6-46F9-BDE8-932CED138EDAQ44147123-58F69409-EC44-4343-BFA8-7E5BD1F9B1E2Q46512954-C6908456-05FE-493F-9106-4B254559782EQ51744373-C4B518CA-6531-4D9F-8022-F124205B51DEQ51801646-C2F9D94E-C0C7-4F49-B0CE-8F6F43E5AD58Q54069177-16E1BEDB-EA35-4E6D-9E33-74FA5B598782
P2860
Modulation of human type II secretory phospholipase A2 by sphingomyelin and annexin VI.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Modulation of human type II secretory phospholipase A2 by sphingomyelin and annexin VI.
@en
Modulation of human type II secretory phospholipase A2 by sphingomyelin and annexin VI.
@nl
type
label
Modulation of human type II secretory phospholipase A2 by sphingomyelin and annexin VI.
@en
Modulation of human type II secretory phospholipase A2 by sphingomyelin and annexin VI.
@nl
prefLabel
Modulation of human type II secretory phospholipase A2 by sphingomyelin and annexin VI.
@en
Modulation of human type II secretory phospholipase A2 by sphingomyelin and annexin VI.
@nl
P2093
P2860
P356
P1433
P1476
Modulation of human type II secretory phospholipase A2 by sphingomyelin and annexin VI.
@en
P2093
P2860
P304
P356
10.1042/BJ3260227
P407
P478
326 ( Pt 1)
P577
1997-08-01T00:00:00Z